FDA — authorised 8 January 1993
- Marketing authorisation holder: GE HEALTHCARE
- Status: approved
FDA authorised Omniscan on 8 January 1993
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 8 January 1993; FDA authorised it on 8 January 1993; FDA authorised it on 5 September 2007.
GE HEALTHCARE holds the US marketing authorisation.